kampirone has been researched along with harmine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goncharenko, NV; Pankrat'ev, DV; Talalaenko, AN | 1 |
| Goncharenko, NV; Krivobok, GK; Pankrat'ev, DV; Talalaenko, AN | 1 |
2 other study(ies) available for kampirone and harmine
| Article | Year |
|---|---|
[Neurochemical characteristics of the ventromedial hypothalamus and anti-aversive effects of anxiolytic agents in various anxiety models].
Topics: Adrenergic alpha-Antagonists; Amino Acids; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Biogenic Monoamines; Chlordiazepoxide; Dopamine D2 Receptor Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Harmine; Hypothalamus, Middle; Microinjections; Piperazines; Pyrimidines; Rats; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Serotonin Agents | 2001 |
Neurochemical mechanisms of the dorsal pallidum in the antiaversive effects of anxiolytics in various models of anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Behavior, Animal; Biogenic Amines; Chlordiazepoxide; Fear; gamma-Aminobutyric Acid; Globus Pallidus; Glutamic Acid; Harmine; Male; Microinjections; Neurotransmitter Agents; Piperazines; Pyrimidines; Rats; Statistics, Nonparametric | 2006 |